Patents by Inventor Victor A. Gault

Victor A. Gault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders
    Patent number: 11738065
    Abstract: The present invention relates to polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders. Also disclosed are pharmaceutical compositions comprising the polypeptides and analogues thereof, and methods for the treatment of diabetes and bone disorders.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: August 29, 2023
    Assignee: UNIVERSITY OF ULSTER
    Inventors: Victor Gault, Nigel Irwin
  • POLYPEPTIDES AND ANALOGUES THEREOF FOR USE IN THE TREATMENT OF DIABETES AND BONE DISORDERS
    Publication number: 20210379157
    Abstract: The present invention relates to polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders. Also disclosed are pharmaceutical compositions comprising the polypeptides and analogues thereof, and methods for the treatment of diabetes and bone disorders.
    Type: Application
    Filed: January 11, 2021
    Publication date: December 9, 2021
    Applicant: UNIVERSITY OF ULSTER
    Inventors: Victor GAULT, Nigel IRWIN
  • Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders
    Patent number: 10888604
    Abstract: The present invention relates to polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders. Also disclosed are pharmaceutical compositions comprising the polypeptides and analogues thereof, and methods for the treatment of diabetes and bone disorders.
    Type: Grant
    Filed: December 5, 2016
    Date of Patent: January 12, 2021
    Inventors: Victor Gault, Nigel Irwin
  • POLYPEPTIDES AND ANALOGUES THEREOF FOR USE IN THE TREATMENT OF DIABETES AND BONE DISORDERS
    Publication number: 20190091294
    Abstract: The present invention relates to polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders. Also disclosed are pharmaceutical compositions comprising the polypeptides and analogues thereof, and methods for the treatment of diabetes and bone disorders.
    Type: Application
    Filed: December 5, 2016
    Publication date: March 28, 2019
    Applicant: UNIVERSITY OF ULSTER
    Inventors: Victor GAULT, Nigel IRWIN
  • Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
    Patent number: 7875587
    Abstract: The present invention provides peptide analogues which are antagonists of gastric inhibitory peptide (GIP). The peptides, based on GIP 1-42 include substitutions and/or modifications which have enhanced resistance to degradation by the enzyme dipeptidyl peptidase IV (DPP IV). The invention also provides a process of N terminally modifying GIP and the use of the peptide analogues for treatment of diabetes.
    Type: Grant
    Filed: March 5, 2007
    Date of Patent: January 25, 2011
    Assignee: UUTECH Limited
    Inventors: Victor A. Gault, Finbarr Paul Mary O'Harte, Nigel Irwin, Peter Raymond Flatt
  • Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
    Publication number: 20080009603
    Abstract: The present invention provides peptide analogues which are antagonists of gastric inhibitory peptide (GIP). The peptides, based on GIP 1-42 include substitutions and/or modifications which have enhanced resistance to degradation by the enzyme dipeptidyl peptidase IV (DPP IV). The invention also provides a process of N terminally modifying GIP and the use of the peptide analogues for treatment of diabetes.
    Type: Application
    Filed: July 3, 2007
    Publication date: January 10, 2008
    Applicant: UUTECH Limited
    Inventors: Victor Gault, Finbarr O'Harte, Nigel Irwin, Peter Flatt
  • Peptide analogues of GIP for treatment of diapetes, insulin resistance and obesity
    Publication number: 20070167370
    Abstract: The present invention provides peptide analogues which are antagonists of gastric inhibitory peptide (GIP). The peptides, based on GIP 1-42 include substitutions and/or modifications which have enhanced resistance to degradation by the enzyme dipeptidyl peptidase IV (DPP IV). The invention also provides a process of N terminally modifying GIP and the use of the peptide analogues for treatment of diabetes.
    Type: Application
    Filed: March 5, 2007
    Publication date: July 19, 2007
    Applicant: UUTECH Limited
    Inventors: Victor Gault, Finbarr O'Harte, Nigel Irwin, Peter Flatt
  • Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
    Publication number: 20050272652
    Abstract: The present invention provides peptide analogues which are antagonists of gastric inhibitory peptide (GIP). The peptides, based on GIP 1-42 include substitutions and/or modifications which have enhanced resistance to degradation by the enzyme dipeptidyl peptidase IV (DPP IV). The invention also provides a process of N terminally modifying GIP and the use of the peptide analogues for treatment of diabetes.
    Type: Application
    Filed: March 25, 2005
    Publication date: December 8, 2005
    Inventors: Victor Gault, Finbarr O'Harte, Nigel Irwin, Patrick Harriott, Peter Flatt